APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digestive System Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digestive System Disease Treatment Market Outlook and Growth Opportunities 2026

23 December 2025210 pages

Choose your research edition.

Industry ResearchDigestive System Disease Treatment Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Digestive System Disease Treatment Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Digestive System Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digestive System Disease Treatment Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Digestive System Disease Treatment Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Digestive System Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digestive System Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digestive System Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digestive System Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digestive System Disease Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digestive System Disease Treatment market include Zhengdatianqing Pharma, Takeda Pharma, Eisai Co., Teva, Sun Pharma, Shanghai Shangyao, Sanofi, Luoxin Pharma and LIVZON, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digestive System Disease Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digestive System Disease Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digestive System Disease Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digestive System Disease Treatment market.

Digestive System Disease Treatment Segment by Company

Zhengdatianqing Pharma

Takeda Pharma

Eisai Co.

Teva

Sun Pharma

Shanghai Shangyao

Sanofi

Luoxin Pharma

LIVZON

Pfizer

Eastchina Pharma

Bayer

AbbVie

AstraZeneca

Zydus Cadila

Viatris

Intercept

Heron Therapeutics

Dr Falk Pharma

Bausch Health

AOSAIKANG Pharma

Digestive System Disease Treatment Segment by Type

Injection

Tablet

Caspuse

Other

Digestive System Disease Treatment Segment by Application

Hospital

Retail Pharmacy

Other

Digestive System Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digestive System Disease Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digestive System Disease Treatment key companies, revenue, market share, and recent developments.

3. To split the Digestive System Disease Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digestive System Disease Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digestive System Disease Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Digestive System Disease Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive System Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digestive System Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive System Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digestive System Disease Treatment industry.

Chapter 3: Detailed analysis of Digestive System Disease Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digestive System Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digestive System Disease Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digestive System Disease Treatment Industry Trends Table 2. Digestive System Disease Treatment Industry Drivers Table 3. Digestive System Disease Treatment Industry Opportunities and Challenges Table 4. Digestive System Disease Treatment Industry Restraints Table 5. Global Digestive System Disease Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digestive System Disease Treatment Revenue Share by Company (2021-2026) Table 7. Global Digestive System Disease Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digestive System Disease Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Digestive System Disease Treatment Company, Product Type & Application Table 10. Global Digestive System Disease Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digestive System Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Injection Table 15. Significant Companies of Tablet Table 16. Significant Companies of Caspuse Table 17. Significant Companies of Other Table 18. Global Digestive System Disease Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Digestive System Disease Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Digestive System Disease Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Digestive System Disease Treatment Sales Value Share by Type (2021-2026) Table 22. Global Digestive System Disease Treatment Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Retail Pharmacy Table 25. Significant Companies of Other Table 26. Global Digestive System Disease Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Digestive System Disease Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Digestive System Disease Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Digestive System Disease Treatment Sales Value Share by Application (2021-2026) Table 30. Global Digestive System Disease Treatment Sales Value Share by Application (2027-2032) Table 31. Global Digestive System Disease Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Digestive System Disease Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Digestive System Disease Treatment Sales Value Share by Region (2021-2026) Table 34. Global Digestive System Disease Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Digestive System Disease Treatment Sales Value Share by Region (2027-2032) Table 36. Global Digestive System Disease Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Digestive System Disease Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Digestive System Disease Treatment Sales Value Market Share by Country (2021-2026) Table 39. Global Digestive System Disease Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Digestive System Disease Treatment Sales Value Market Share by Country (2027-2032) Table 41. Zhengdatianqing Pharma Company Information Table 42. Zhengdatianqing Pharma Business Overview Table 43. Zhengdatianqing Pharma Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Zhengdatianqing Pharma Digestive System Disease Treatment Product Portfolio Table 45. Zhengdatianqing Pharma Recent Development Table 46. Takeda Pharma Company Information Table 47. Takeda Pharma Business Overview Table 48. Takeda Pharma Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Takeda Pharma Digestive System Disease Treatment Product Portfolio Table 50. Takeda Pharma Recent Development Table 51. Eisai Co. Company Information Table 52. Eisai Co. Business Overview Table 53. Eisai Co. Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Eisai Co. Digestive System Disease Treatment Product Portfolio Table 55. Eisai Co. Recent Development Table 56. Teva Company Information Table 57. Teva Business Overview Table 58. Teva Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Teva Digestive System Disease Treatment Product Portfolio Table 60. Teva Recent Development Table 61. Sun Pharma Company Information Table 62. Sun Pharma Business Overview Table 63. Sun Pharma Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Sun Pharma Digestive System Disease Treatment Product Portfolio Table 65. Sun Pharma Recent Development Table 66. Shanghai Shangyao Company Information Table 67. Shanghai Shangyao Business Overview Table 68. Shanghai Shangyao Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Shanghai Shangyao Digestive System Disease Treatment Product Portfolio Table 70. Shanghai Shangyao Recent Development Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sanofi Digestive System Disease Treatment Product Portfolio Table 75. Sanofi Recent Development Table 76. Luoxin Pharma Company Information Table 77. Luoxin Pharma Business Overview Table 78. Luoxin Pharma Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Luoxin Pharma Digestive System Disease Treatment Product Portfolio Table 80. Luoxin Pharma Recent Development Table 81. LIVZON Company Information Table 82. LIVZON Business Overview Table 83. LIVZON Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. LIVZON Digestive System Disease Treatment Product Portfolio Table 85. LIVZON Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Digestive System Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Pfizer Digestive System Disease Treatment Product Portfolio Table 90. Pfizer Recent Development Table 91. Eastchina Pharma Company Information Table 92. Eastchina Pharma Business Overview Table 93. Eastchina Pharma Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Eastchina Pharma Digestive System Disease Treatment Product Portfolio Table 95. Eastchina Pharma Recent Development Table 96. Bayer Company Information Table 97. Bayer Business Overview Table 98. Bayer Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Bayer Digestive System Disease Treatment Product Portfolio Table 100. Bayer Recent Development Table 101. AbbVie Company Information Table 102. AbbVie Business Overview Table 103. AbbVie Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. AbbVie Digestive System Disease Treatment Product Portfolio Table 105. AbbVie Recent Development Table 106. AstraZeneca Company Information Table 107. AstraZeneca Business Overview Table 108. AstraZeneca Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. AstraZeneca Digestive System Disease Treatment Product Portfolio Table 110. AstraZeneca Recent Development Table 111. Zydus Cadila Company Information Table 112. Zydus Cadila Business Overview Table 113. Zydus Cadila Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Zydus Cadila Digestive System Disease Treatment Product Portfolio Table 115. Zydus Cadila Recent Development Table 116. Viatris Company Information Table 117. Viatris Business Overview Table 118. Viatris Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Viatris Digestive System Disease Treatment Product Portfolio Table 120. Viatris Recent Development Table 121. Intercept Company Information Table 122. Intercept Business Overview Table 123. Intercept Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Intercept Digestive System Disease Treatment Product Portfolio Table 125. Intercept Recent Development Table 126. Heron Therapeutics Company Information Table 127. Heron Therapeutics Business Overview Table 128. Heron Therapeutics Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Heron Therapeutics Digestive System Disease Treatment Product Portfolio Table 130. Heron Therapeutics Recent Development Table 131. Dr Falk Pharma Company Information Table 132. Dr Falk Pharma Business Overview Table 133. Dr Falk Pharma Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Dr Falk Pharma Digestive System Disease Treatment Product Portfolio Table 135. Dr Falk Pharma Recent Development Table 136. Bausch Health Company Information Table 137. Bausch Health Business Overview Table 138. Bausch Health Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Bausch Health Digestive System Disease Treatment Product Portfolio Table 140. Bausch Health Recent Development Table 141. AOSAIKANG Pharma Company Information Table 142. AOSAIKANG Pharma Business Overview Table 143. AOSAIKANG Pharma Digestive System Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. AOSAIKANG Pharma Digestive System Disease Treatment Product Portfolio Table 145. AOSAIKANG Pharma Recent Development Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Digestive System Disease Treatment Product Image Figure 2. Global Digestive System Disease Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Digestive System Disease Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Injection Image Figure 8. Tablet Image Figure 9. Caspuse Image Figure 10. Other Image Figure 11. Global Digestive System Disease Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Digestive System Disease Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Digestive System Disease Treatment Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Retail Pharmacy Image Figure 16. Other Image Figure 17. Global Digestive System Disease Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Digestive System Disease Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Digestive System Disease Treatment Sales Value Share by Application (2021-2032) Figure 20. Global Digestive System Disease Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Digestive System Disease Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Digestive System Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 23. North America Digestive System Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Digestive System Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Digestive System Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Digestive System Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Digestive System Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Digestive System Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 29. South America Digestive System Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Digestive System Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Digestive System Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Digestive System Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Caspuse
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Zhengdatianqing Pharma
  • Takeda Pharma
  • Eisai Co.
  • Teva
  • Sun Pharma
  • Shanghai Shangyao
  • Sanofi
  • Luoxin Pharma
  • LIVZON
  • Pfizer
  • Eastchina Pharma
  • Bayer
  • AbbVie
  • AstraZeneca
  • Zydus Cadila
  • Viatris
  • Intercept
  • Heron Therapeutics
  • Dr Falk Pharma
  • Bausch Health
  • AOSAIKANG Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digestive System Disease Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digestive System Disease Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digestive System Disease Treatment Market Dynamics
  1. 2.1 Digestive System Disease Treatment Industry Trends
  2. 2.2 Digestive System Disease Treatment Industry Drivers
  3. 2.3 Digestive System Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Digestive System Disease Treatment Industry Restraints
3 Digestive System Disease Treatment Market by Company
  1. 3.1 Global Digestive System Disease Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Digestive System Disease Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Digestive System Disease Treatment Company Ranking (2024-2026)
  4. 3.4 Global Digestive System Disease Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Digestive System Disease Treatment Company Product Type and Application
  6. 3.6 Global Digestive System Disease Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digestive System Disease Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digestive System Disease Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digestive System Disease Treatment Market by Type
  1. 4.1 Digestive System Disease Treatment Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Tablet
  4. 4.1.3 Caspuse
  5. 4.1.4 Other
  6. 4.2 Global Digestive System Disease Treatment Sales Value by Type
  7. 4.2.1 Global Digestive System Disease Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Digestive System Disease Treatment Sales Value by Type (2021-2032)
  9. 4.2.3 Global Digestive System Disease Treatment Sales Value Share by Type (2021-2032)
5 Digestive System Disease Treatment Market by Application
  1. 5.1 Digestive System Disease Treatment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Digestive System Disease Treatment Sales Value by Application
  6. 5.2.1 Global Digestive System Disease Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Digestive System Disease Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Digestive System Disease Treatment Sales Value Share by Application (2021-2032)
6 Digestive System Disease Treatment Regional Value Analysis
  1. 6.1 Global Digestive System Disease Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digestive System Disease Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digestive System Disease Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digestive System Disease Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digestive System Disease Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Digestive System Disease Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digestive System Disease Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Digestive System Disease Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digestive System Disease Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digestive System Disease Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digestive System Disease Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Digestive System Disease Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digestive System Disease Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digestive System Disease Treatment Sales Value Share by Country, 2025 VS 2032
7 Digestive System Disease Treatment Country-level Value Analysis
  1. 7.1 Global Digestive System Disease Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digestive System Disease Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digestive System Disease Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digestive System Disease Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digestive System Disease Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digestive System Disease Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digestive System Disease Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhengdatianqing Pharma
  2. 8.1.1 Zhengdatianqing Pharma Company Information
  3. 8.1.2 Zhengdatianqing Pharma Business Overview
  4. 8.1.3 Zhengdatianqing Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhengdatianqing Pharma Digestive System Disease Treatment Product Portfolio
  6. 8.1.5 Zhengdatianqing Pharma Recent Developments
  7. 8.2 Takeda Pharma
  8. 8.2.1 Takeda Pharma Company Information
  9. 8.2.2 Takeda Pharma Business Overview
  10. 8.2.3 Takeda Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharma Digestive System Disease Treatment Product Portfolio
  12. 8.2.5 Takeda Pharma Recent Developments
  13. 8.3 Eisai Co.
  14. 8.3.1 Eisai Co. Company Information
  15. 8.3.2 Eisai Co. Business Overview
  16. 8.3.3 Eisai Co. Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eisai Co. Digestive System Disease Treatment Product Portfolio
  18. 8.3.5 Eisai Co. Recent Developments
  19. 8.4 Teva
  20. 8.4.1 Teva Company Information
  21. 8.4.2 Teva Business Overview
  22. 8.4.3 Teva Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Digestive System Disease Treatment Product Portfolio
  24. 8.4.5 Teva Recent Developments
  25. 8.5 Sun Pharma
  26. 8.5.1 Sun Pharma Company Information
  27. 8.5.2 Sun Pharma Business Overview
  28. 8.5.3 Sun Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sun Pharma Digestive System Disease Treatment Product Portfolio
  30. 8.5.5 Sun Pharma Recent Developments
  31. 8.6 Shanghai Shangyao
  32. 8.6.1 Shanghai Shangyao Company Information
  33. 8.6.2 Shanghai Shangyao Business Overview
  34. 8.6.3 Shanghai Shangyao Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Shangyao Digestive System Disease Treatment Product Portfolio
  36. 8.6.5 Shanghai Shangyao Recent Developments
  37. 8.7 Sanofi
  38. 8.7.1 Sanofi Company Information
  39. 8.7.2 Sanofi Business Overview
  40. 8.7.3 Sanofi Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Digestive System Disease Treatment Product Portfolio
  42. 8.7.5 Sanofi Recent Developments
  43. 8.8 Luoxin Pharma
  44. 8.8.1 Luoxin Pharma Company Information
  45. 8.8.2 Luoxin Pharma Business Overview
  46. 8.8.3 Luoxin Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Luoxin Pharma Digestive System Disease Treatment Product Portfolio
  48. 8.8.5 Luoxin Pharma Recent Developments
  49. 8.9 LIVZON
  50. 8.9.1 LIVZON Company Information
  51. 8.9.2 LIVZON Business Overview
  52. 8.9.3 LIVZON Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LIVZON Digestive System Disease Treatment Product Portfolio
  54. 8.9.5 LIVZON Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Digestive System Disease Treatment Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 Eastchina Pharma
  62. 8.11.1 Eastchina Pharma Company Information
  63. 8.11.2 Eastchina Pharma Business Overview
  64. 8.11.3 Eastchina Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eastchina Pharma Digestive System Disease Treatment Product Portfolio
  66. 8.11.5 Eastchina Pharma Recent Developments
  67. 8.12 Bayer
  68. 8.12.1 Bayer Company Information
  69. 8.12.2 Bayer Business Overview
  70. 8.12.3 Bayer Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bayer Digestive System Disease Treatment Product Portfolio
  72. 8.12.5 Bayer Recent Developments
  73. 8.13 AbbVie
  74. 8.13.1 AbbVie Company Information
  75. 8.13.2 AbbVie Business Overview
  76. 8.13.3 AbbVie Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AbbVie Digestive System Disease Treatment Product Portfolio
  78. 8.13.5 AbbVie Recent Developments
  79. 8.14 AstraZeneca
  80. 8.14.1 AstraZeneca Company Information
  81. 8.14.2 AstraZeneca Business Overview
  82. 8.14.3 AstraZeneca Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AstraZeneca Digestive System Disease Treatment Product Portfolio
  84. 8.14.5 AstraZeneca Recent Developments
  85. 8.15 Zydus Cadila
  86. 8.15.1 Zydus Cadila Company Information
  87. 8.15.2 Zydus Cadila Business Overview
  88. 8.15.3 Zydus Cadila Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Zydus Cadila Digestive System Disease Treatment Product Portfolio
  90. 8.15.5 Zydus Cadila Recent Developments
  91. 8.16 Viatris
  92. 8.16.1 Viatris Company Information
  93. 8.16.2 Viatris Business Overview
  94. 8.16.3 Viatris Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Viatris Digestive System Disease Treatment Product Portfolio
  96. 8.16.5 Viatris Recent Developments
  97. 8.17 Intercept
  98. 8.17.1 Intercept Company Information
  99. 8.17.2 Intercept Business Overview
  100. 8.17.3 Intercept Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Intercept Digestive System Disease Treatment Product Portfolio
  102. 8.17.5 Intercept Recent Developments
  103. 8.18 Heron Therapeutics
  104. 8.18.1 Heron Therapeutics Company Information
  105. 8.18.2 Heron Therapeutics Business Overview
  106. 8.18.3 Heron Therapeutics Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Heron Therapeutics Digestive System Disease Treatment Product Portfolio
  108. 8.18.5 Heron Therapeutics Recent Developments
  109. 8.19 Dr Falk Pharma
  110. 8.19.1 Dr Falk Pharma Company Information
  111. 8.19.2 Dr Falk Pharma Business Overview
  112. 8.19.3 Dr Falk Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Dr Falk Pharma Digestive System Disease Treatment Product Portfolio
  114. 8.19.5 Dr Falk Pharma Recent Developments
  115. 8.20 Bausch Health
  116. 8.20.1 Bausch Health Company Information
  117. 8.20.2 Bausch Health Business Overview
  118. 8.20.3 Bausch Health Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Bausch Health Digestive System Disease Treatment Product Portfolio
  120. 8.20.5 Bausch Health Recent Developments
  121. 8.21 AOSAIKANG Pharma
  122. 8.21.1 AOSAIKANG Pharma Company Information
  123. 8.21.2 AOSAIKANG Pharma Business Overview
  124. 8.21.3 AOSAIKANG Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  125. 8.21.4 AOSAIKANG Pharma Digestive System Disease Treatment Product Portfolio
  126. 8.21.5 AOSAIKANG Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst